Unknown

Dataset Information

0

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes


ABSTRACT:

SUBMITTER: Galtier J 

PROVIDER: S-EPMC8590686 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8008421 | biostudies-literature
| S-EPMC8085967 | biostudies-literature
| S-EPMC5518888 | biostudies-other
| S-EPMC6286323 | biostudies-literature
| S-EPMC9746059 | biostudies-literature
| S-EPMC5756334 | biostudies-literature
| S-EPMC3023007 | biostudies-literature
| S-EPMC10067034 | biostudies-literature
| S-EPMC7540307 | biostudies-literature
| S-EPMC4822512 | biostudies-literature